A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-1)
Research Grant
Awarded By
4D Molecular Therapeutics
Start Date
December 17, 2024
End Date
August 16, 2028
Awarded By
4D Molecular Therapeutics
Start Date
December 17, 2024
End Date
August 16, 2028